Related Experiment Video
Updated: Jun 11, 2026

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models
Published on: March 13, 2018
Radiolabeled nucleoside analogues for PET imaging of HSV1-tk gene expression
Mian M Alauddin1, Juri G Gelovani
1The University of Texas MD Anderson Cancer Center, Houston, TX, USA. alauddin@mdanderson.org
Abstract:
The HSV1-tk gene has been explored as a reporter and/or suicide gene in molecular imaging of gene expression. Gene therapy with HSV1-tk and the use of this gene as a marker have been applied in patients with various forms of cancer. However, the conditions for clinical gene therapy protocols have yet to be optimized. A method to monitor the activity of HSV-tk in vivo would be extremely useful to optimize clinical gene therapy protocols. Positron emission tomography (PET) with a suitable probe can offer information about both the extent of gene expression and its distribution, provided that an appropriate reporter gene is included in the therapeutic cassette. PET imaging provides higher resolution and sensitivity and allows noninvasive quantification of biological processes. Several radiolabeled pyrimidine (thymidine) and purine (acycloguanosine) derivatives have been developed as reporter probes for imaging of HSV-TK enzyme activity with PET. In this review, information on radiolabeling and PET imaging of HSV1-tk gene expression with various nucleoside analogues is presented.
Insights
Monitoring Herpes Simplex Virus type 1 thymidine kinase (HSV1-tk) activity in vivo is crucial for optimizing gene therapy. Positron emission tomography (PET) imaging with nucleoside analogues offers a noninvasive method to track HSV1-tk gene expression and distribution.
Area of Science:
- Molecular Biology
- Biotechnology
- Medical Imaging
Background:
- The Herpes Simplex Virus type 1 thymidine kinase (HSV1-tk) gene is utilized as a reporter and suicide gene in molecular imaging and cancer gene therapy.
- Clinical gene therapy protocols involving HSV1-tk require optimization, necessitating in vivo monitoring of gene activity.
Purpose of the Study:
- To review methods for in vivo monitoring of HSV1-tk enzyme activity using Positron Emission Tomography (PET).
- To present information on radiolabeling and PET imaging of HSV1-tk gene expression with various nucleoside analogues.
Main Methods:
- Review of radiolabeled nucleoside analogues as reporter probes for HSV-TK enzyme activity.
- Discussion of Positron Emission Tomography (PET) imaging principles for gene expression monitoring.
Main Results:
- Development of several radiolabeled pyrimidine (thymidine) and purine (acycloguanosine) derivatives for PET imaging of HSV-TK activity.
- PET imaging allows noninvasive quantification of gene expression extent and distribution with high resolution and sensitivity.
Conclusions:
- In vivo monitoring of HSV1-tk activity via PET is essential for optimizing gene therapy protocols.
- Radiolabeled nucleoside analogues serve as effective probes for PET imaging of HSV1-tk gene expression.
More Related Videos
13:22Detection of the Genome and Transcripts of a Persistent DNA Virus in Neuronal Tissues by Fluorescent In situ Hybridization Combined with Immunostaining
Published on: January 23, 2014
06:21Quantitative Fluorescence In Situ Hybridization (FISH) and Immunofluorescence (IF) of Specific Gene Products in KSHV-Infected Cells
Published on: August 27, 2019
Related Concept Videos
Herpes
Antiviral Nucleoside Inhibitors
Labeling DNA Probes
Radioisotopes, fluorophores, or small molecule binding partners like biotin or digoxigenin, are the most widely used reporter tags for labeling DNA probes. These labels can be attached to the probe DNA molecule via...